Rio Grande Valley residents who have developed antibodies to COVID-19 have the potential to save lives of seriously-ill hospital patients who are suffering from that infectious and dangerous disease, according to Sohail Rao, MD, MA, DPHIL, President and CEO for DHR Health Institute for Research and Development. “When the COVID pandemic hit the nation (in March 2020), we started a process of creating some therapeutic options for our patients and our physicians,” said Rao. “At that time, and still, the only therapeutic tool that is available to treat COVID-19 infection is transfusing (convalescent) plasma to these patients.” Plasma is the liquid portion ...